Publications
Export 10 results:
Filters: Author is Poulin, Hugo [Clear All Filters]
“De novo Y1460C missense variant in Na1.1 impedes the pore region and results in epileptic encephalopathy.”, Sci Rep, vol. 12, no. 1, p. 17182, 2022.
“-related epilepsy of infancy with migrating focal seizures: report of a variant with apparent gain- and loss-of-function effects.”, J Neurophysiol, vol. 127, no. 5, pp. 1388-1397, 2022.
, “Na1.5 knockout in iPSCs: a novel approach to study Na1.5 variants in a human cardiomyocyte environment.”, Sci Rep, vol. 11, no. 1, p. 17168, 2021.
, “R1617Q epilepsy mutation slows Na 1.6 sodium channel inactivation and increases the persistent current and neuronal firing.”, J Physiol, vol. 599, no. 5, pp. 1651-1664, 2021.
, “A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis.”, Neurology, vol. 86, no. 2, pp. 161-9, 2016.
, “Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.”, Eur J Pharmacol, vol. 764, pp. 395-403, 2015.
, “Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics.”, Mol Pharmacol, vol. 86, no. 4, pp. 378-89, 2014.
, “Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.”, Eur J Pharmacol, vol. 727, pp. 158-66, 2014.
, “Pyridoxal-5'-phosphate (MC-1), a vitamin B6 derivative, inhibits expressed P2X receptors.”, Can J Physiol Pharmacol, vol. 92, no. 3, pp. 189-96, 2014.
, “The variant hERG/R148W associated with LQTS is a mutation that reduces current density on co-expression with the WT.”, Gene, vol. 536, no. 2, pp. 348-56, 2014.
